UPLOAD Filing
Alps Group Inc
Date: Sept. 5, 2025 · CIK: 0002025774 · Accession: 0000000000-25-009635
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284035
Letter
Re: Alps Global Holding Pubco Amendment No. 7 to Registration Statement on Form F-4 Filed August 29, 2025 File No. 333-284035 Dear Say Leong Lim and Tham Seng Kong:
September 5, 2025
Say Leong Lim Chief Executive Officer and Chairman of the Board of Directors Alps Global Holding Pubco Unit E-18-01 & E-18-02, Level 18, Icon Tower (East) No. 1, Jalan 1/68F, Jalan Tun Razak 50400 Kuala Lumpur Wilayah Persekutuan, Malaysia
Tham Seng Kong Chief Executive Officer Alps Life Sciences Inc Unit E-18-01 & E-18-02, Level 18, Icon Tower (East) No. 1, Jalan 1/68F, Jalan Tun Razak 50400 Kuala Lumpur Wilayah Persekutuan, Malaysia
We have reviewed your amended registration statement and have the following comment.
Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our August 4, 2025 letter. September 5, 2025 Page 2
Amendment No. 7 to Registration Statement on Form F-4 Filed August 29, 2025 Item 21. Exhibits and Financial Statements Schedules Exhibit 23.2 and Exhibit 23.5, page II-2
1. Please provide a currently dated consent from your auditors. Refer to Item 601(b)(23)(i) of Regulation S-K. Please contact Nudrat Salik at 202-551-3692 or Li Xiao at 202-551-4391 if you have questions regarding comments on the financial statements and related matters. Please contact Conlon Danberg at 202-551-4466 or Lauren Nguyen at 202-551-3642 with any other questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Jenny Chen-Drake, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 5, 2025 Say Leong Lim Chief Executive Officer and Chairman of the Board of Directors Alps Global Holding Pubco Unit E-18-01 & E-18-02, Level 18, Icon Tower (East) No. 1, Jalan 1/68F, Jalan Tun Razak 50400 Kuala Lumpur Wilayah Persekutuan, Malaysia Tham Seng Kong Chief Executive Officer Alps Life Sciences Inc Unit E-18-01 & E-18-02, Level 18, Icon Tower (East) No. 1, Jalan 1/68F, Jalan Tun Razak 50400 Kuala Lumpur Wilayah Persekutuan, Malaysia Re: Alps Global Holding Pubco Amendment No. 7 to Registration Statement on Form F-4 Filed August 29, 2025 File No. 333-284035 Dear Say Leong Lim and Tham Seng Kong: We have reviewed your amended registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our August 4, 2025 letter. September 5, 2025 Page 2 Amendment No. 7 to Registration Statement on Form F-4 Filed August 29, 2025 Item 21. Exhibits and Financial Statements Schedules Exhibit 23.2 and Exhibit 23.5, page II-2 1. Please provide a currently dated consent from your auditors. Refer to Item 601(b)(23)(i) of Regulation S-K. Please contact Nudrat Salik at 202-551-3692 or Li Xiao at 202-551-4391 if you have questions regarding comments on the financial statements and related matters. Please contact Conlon Danberg at 202-551-4466 or Lauren Nguyen at 202-551-3642 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Jenny Chen-Drake, Esq. </TEXT> </DOCUMENT>